Expression of the ARG2 protein was evaluated in clinical samples by immunohistochemistry on three different tissue micro-arrays (TMAs) regrouping prostate samples from a cohort of 99 PCa patients and 50 normal prostate obtained from autopsies. This evidence concerns the gene ARG2 and posterior cortical atrophy.